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Abstract 
Non-coding Y RNAs are essential for the initiation of chromosomal DNA replication in 
vertebrates, yet their association with chromatin during the cell cycle is not 
characterised. Here, we quantify human Y RNA levels in soluble and chromatin-
associated intracellular fractions and investigate topographically their dynamic 
association with chromatin during the cell cycle. We find that, on average, about a 
million Y RNA molecules are present in the soluble fraction of a proliferating cell, and 
5-10-fold less in association with chromatin. These levels decrease substantially in 
quiescence. No significant differences are apparent between cancer and non-cancer 
cell lines. Y RNAs associate with euchromatin throughout the cell cycle. Their levels 
are 2-4-fold higher in S than in G1 phase or mitosis. Y RNAs are not detectable at 
active DNA replication foci, and re-associate with replicated euchromatin during 
mid/late S phase. The dynamics and sites of Y1 RNA association with chromatin are 
concordant with those of the origin recognition complex, ORC. Our data therefore 
suggest a functional role of Y RNAs in a common pathway with ORC. 
 
 
 
Summary statement 
Non-coding Y RNAs are essential for DNA replication. We show that they associate 
with euchromatin in a cell cycle regulated manner concordantly with the origin 
recognition complex ORC, suggesting a concerted function. 
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Introduction 
Y RNAs are abundant small non-coding RNAs in vertebrates (Hall et al., 2013; 
Kowalski and Krude, 2015). In human cells, four single-copy genes are transcribed by 
RNA polymerase III into the Y1, Y3, Y4 and Y5 RNAs of 112, 101, 93 and 83 
nucleotides, respectively (Hendrick et al., 1981; Wolin and Steitz, 1983). The 5' and 3' 
RNA ends hybridise to form a double-stranded stem domain that encompasses an 
internal single-stranded loop domain (Teunissen et al., 2000; van Gelder et al., 1994). 
Nucleotide sequences of the stem are highly conserved, but those of the loop vary 
considerably. The structurally related stem-bulge RNAs (sbRNAs) in nematodes are 
homologues of vertebrate Y RNAs (Boria et al., 2010; Kowalski et al., 2015). 
Y RNAs have a functional role in the replication of chromosomal DNA in vertebrate 
cells (Christov et al., 2006; Christov et al., 2008; Collart et al., 2011; Gardiner et al., 
2009; Kowalski and Krude, 2015; Krude et al., 2009). They were identified as an 
essential activity for the initiation of chromosomal DNA replication in a human cell-free 
system (Christov et al., 2006; Krude et al., 2009). Degradation of Y RNAs in vitro 
inhibits the initiation step of chromosomal DNA replication in cell-free extracts and 
RNA interference or functional depletion in vivo inhibits DNA replication and cell 
proliferation in vertebrate cells and causes death in developing vertebrate embryos 
(Christov et al., 2006; Christov et al., 2008; Collart et al., 2011). DNA replication is 
restored by the addition of any human or vertebrate Y RNAs to Y RNA-depleted cell-
free extracts in vitro, or to vertebrate cells following RNA interference in vivo. In 
contrast, addition of ribosomal 5S rRNA or spliceosomal U2 snRNA has no effect 
(Christov et al., 2006; Collart et al., 2011; Gardiner et al., 2009). Therefore, vertebrate 
Y RNAs are required specifically for DNA replication, and they function redundantly 
with each other. This functional redundancy arises from the presence of an 
evolutionarily conserved structural motif present on the upper stem of vertebrate Y 
RNAs that is essential and sufficient for DNA replication (Gardiner et al., 2009; Wang 
et al., 2014). Consistent with a functional role in DNA replication and cell proliferation, 
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Y RNAs are over-expressed in human solid tumour tissues, when compared with 
corresponding healthy normal tissues (Christov et al., 2008). 
Vertebrate DNA replication is regulated during the cell cycle by the stepwise 
assembly and subsequent activation of multisubunit protein complexes at replication 
origins (reviewed by (Arias and Walter, 2007; Costa et al., 2013; Fragkos et al., 2015; 
O'Donnell et al., 2013; Siddiqui et al., 2013)). During G1 phase chromatin-associated 
origin recognition complex (ORC) directs the assembly of the pre-replication complex 
(pre-RC; or replication licence) at replication origin sites, involving the recruitment of 
Cdt1, Cdc6 and MCM2-7 proteins to chromatin. During S phase, pre-RCs are 
converted to initiation complexes (ICs) at activated origin sites and eventually to 
replication fork complexes. This activation cascade involves CDK and DDK protein 
kinase activities and the recruitment of additional proteins, including GINS, Cdc45, 
DNA polymerases and many others. Crucially, after executing their function, essential 
subunits dissociate from the respective preRC, IC and replication fork complexes 
again, while key subunits of ORC remain associated with chromatin during the cell 
cycle. This process is conserved in eukaryotes. 
The molecular mechanism of Y RNA function during DNA replication is not clear, 
although key features are emerging. Y RNAs interact biochemically with ORC, preRC 
components and other DNA replication initiation proteins, but not with DNA replication 
fork proteins (Collart et al., 2011; Zhang et al., 2011). During early development of X. 
laevis, Y RNA binds to chromatin after the mid-blastula stage in an ORC-dependent 
manner (Collart et al., 2011). During the G1 to S phase transition in vitro, 
fluorescently labelled human Y RNAs associate dynamically with unreplicated 
chromatin before initiation, where they co-localise with ORC, and the preRC/IC 
proteins Cdt1, MCM2 and Cdc45 (Zhang et al., 2011). Once DNA replication initiates 
in a Y RNA-dependent manner, Y RNAs are displaced locally and absent from sites 
of ongoing DNA synthesis, suggesting they might act as DNA replication licensing 
factors (Zhang et al., 2011). However, Y RNAs are abundant molecules, and a 
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comprehensive and quantitative investigation of the intracellular localisation of Y 
RNAs during the cell cycle has not been reported to date. 
In this paper, we report the quantification of human Y RNAs in the soluble and 
chromatin-associated intracellular fractions in a panel of human cells. We investigate 
their dynamic association with chromatin during the cell cycle, and in quiescence. 
Using complementary approaches, we show that Y RNAs levels correlate with the 
proliferative state of human cells and that they associate preferentially with S phase 
chromatin. The dynamics of Y RNA association with chromatin throughout the cell 
cycle closely follow those of the origin recognition complex ORC rather than MCM or 
other licensing factors, suggesting that Y RNAs act in a common pathway with ORC. 
 
 
Results 
 
Quantification of Y RNAs in proliferating human cancer and non-cancer cell 
lines 
We quantified amounts of intracellular Y RNA molecules in twelve human cell lines of 
cancer and non-cancer origin (Fig. 1 and supplementary Tab. S1). Cells were grown 
as proliferating cultures, and then fractionated into soluble and chromatin-associated 
cellular compartments. After RNA extraction and cDNA synthesis, we quantified Y 
RNAs in these fractions by RT-PCR using Y RNA-specific primer pairs (Christov et 
al., 2006). To obtain absolute numbers of Y RNA molecules per cell for each 
intracellular fraction, we normalised the qRT-PCR data against defined amounts of Y 
RNA-specific calibrator plasmids and against the number of cells used for RNA 
extraction (Fig. 1).  
Overall, we detected an average of a million soluble Y RNA molecules per cell (Fig. 
1A). Y3 RNA was most abundant, followed by Y1, Y5 and Y4. However, this value 
varied between cell lines to an order of magnitude. There was no significant 
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difference in soluble Y RNA levels between cancer and non-cancer derived cell lines.  
In the chromatin-associated fraction, we detected an average of 150,000 Y RNA 
molecules per cell (Fig. 1B). Y1 and Y3 RNAs were most abundant, followed by Y5 
and Y4 RNA. Again, there was no significant difference between cancer and non-
cancer cell lines and the overall amount of chromatin-associated Y RNA molecules 
varied considerably between the different cell lines (Fig. 1B). However, the relative 
proportions of chromatin-associated Y RNAs varied little (Fig. 1C).  
We conclude that chromatin-associated Y RNAs account for an average of 10-15% of 
the total Y RNA in a proliferating cell, independent of whether it is cancer-derived or 
not. 
 
Y RNA levels are decreased in quiescence 
Y RNAs are significantly over-expressed in human solid tumours compared to 
corresponding normal tissues (Christov et al., 2008), yet we found no significantly 
different amounts between proliferating human cancer and non-cancer derived cell 
lines. This raises the possibility that Y RNAs may in fact be down-regulated in normal 
tissues, where most cells are quiescent and do not proliferate in situ, unlike tumour 
tissues or proliferating cell lines in culture. We therefore compared the absolute 
amounts of soluble and chromatin-associated Y RNA molecules in quiescent and 
proliferating cells (Fig. S1). 
We induced quiescence in EJ30 bladder carcinoma, HCA-7 colon adenocarcinoma 
and hTERT-immortalised normal RPE-1 retinal pigment epithelial cells (Fig. S1A). 
There was an overall and significant 2-5 fold decrease in the total numbers of Y RNA 
molecules in the quiescent cells (T-tests, unpaired, two-tailed, P<0.03), which 
affected both soluble and chromatin-associated cellular compartments equally (Fig. 
S1B-D). 
We conclude that Y RNA expression is systematically elevated in proliferating cells 
compared to quiescent ones. This up-regulation is consistent with the essential 
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function of Y RNAs during the initiation of chromosomal DNA replication (Christov et 
al., 2006; Krude et al., 2009). 
 
Elevated levels of chromatin-associated Y RNAs during S phase 
We characterised next the expression levels and intracellular partition of Y RNAs 
during the cell cycle. HeLa cells were chemically synchronised at mitosis, in early, 
mid, and late G1, in early, early/mid, mid S, and late S/G2 phase. We confirmed cell 
synchrony by flow cytometry (Fig. 2A) and by determining the percentages of actively 
replicating cell nuclei (Fig. 2B). 
The overall number of soluble Y RNA molecules per cell varied non-significantly 
between different the cell cycle phases (Fig. 2C). Y3 RNA was the most abundant in 
the soluble fraction, and the relative proportions of the four Y RNAs did not change 
during the cell cycle (Fig. 2C). 
In contrast, the amounts of chromatin-associated Y RNAs per cell changed 
systematically and significantly during the cell cycle (Fig. 2D). The total numbers of 
chromatin-associated Y RNAs ranged between 300,000 and 500,000 molecules per 
cell in mitosis and G1 phase (Fig. 2D). As cells entered S phase, the number 
increased significantly to 950,000 in early S phase and reached 1.2 million molecules 
per cell in mid/late S (Fig. 2D). Furthermore, the relative proportions of the four Y 
RNAs also changed as cells entered S phase. Y1 RNA became the most abundant 
(Fig. 2D) and the proportions of chromatin-associated Y1 and Y5 RNA increased 
substantially (Fig. 2E). 
To substantiate these findings independently, we also quantified amounts of Y RNAs 
in soluble and chromatin-associated fractions in human EJ30 cells that were made 
quiescent by serum starvation and subsequently released into the proliferative cell 
cycle (Fig. S2A). As cells exited quiescence and traversed G1 phase for 13h, the 
number of soluble and chromatin-associated Y RNAs increased about five-fold, 
suggesting that their expression is up-regulated upon exit from quiescence into G1 
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phase (Fig. S2B). When cells had entered S phase by 25h, the absolute numbers of 
soluble Y RNAs dropped while chromatin-associated Y RNAs increased four-fold, 
leading to substantially increased proportions of chromatin-associated individual Y 
RNAs (Fig. S2B). 
Taken together, our data suggest that the association of Y RNAs with the insoluble 
nuclear chromatin fraction is regulated during the cell cycle, resulting in a significantly 
increased proportion of Y RNAs associated with chromatin during S phase. 
 
Increased association of Y RNAs with S phase chromatin in vitro  
Previous in vitro studies revealed a rapid dynamic association of fluorescently 
labelled Y RNAs with chromatin in nuclei crossing the G1 to S phase boundary 
(Zhang et al., 2011). We adapted this assay to visualise and quantify the association 
of fluorescent Y RNAs to nuclei from synchronised HeLa cells (Fig. 3). We compared 
the chromatin binding of fluorescent Alexa-488-labelled Y1 RNA with that of 5S rRNA 
and spliceosomal U2 snRNA. A substantial amount of Y1 RNA associated with G1 
and S phase nuclei, whereas an association of U2 and 5S RNAs was barely 
detectable under these conditions (Fig. 3A). Next, we quantified this association by 
measuring the integrated fluorescence pixel density over the nuclear area (Fig. 3B). 
The mean binding of Alexa-488-Y1 RNA to G1 and S phase nuclei was about twenty-
fold higher than that of U2 or 5S rRNA and the association of Y1 RNA was more 
efficient in S phase nuclei compared to G1 phase nuclei (Fig. 3B). We therefore 
quantified the association of Alexa-488-labelled Y1 RNA with nuclei from 
synchronised cells at higher temporal resolution (Fig. 3C). The association of Y1 RNA 
with early, mid and late S phase nuclei was significantly and two-fold higher than with 
early to late G1 phase nuclei, as indicated by the two-fold increases of means and 
medians between these distributions. We observed a similar effect with Alexa-488-
labelled Y5 RNA (data not shown). 
To independently confirm this analysis, we also measured the amounts of Y1 RNA 
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associating in vitro with nuclei from EJ30 cells synchronised by serum starvation and 
release (Fig. S2C). Significantly increased amounts of Y1 associated with S phase 
nuclei in vitro, compared to quiescent or G1 phase nuclei. 
However, this quantitative RNA binding analysis is subject to caveats of cell 
synchronisation effects and technical variability between individual reactions. To 
circumvent these, we compared the binding of Alexa-488-labelled Y1 RNA to nuclei of 
asynchronously proliferating HeLa cells within one reaction (Fig. S3A). S phase nuclei 
were identified by nuclear run-on replication taking place during the RNA binding 
reaction in vitro and subsequent visualisation of DNA replication foci by 
immunofluorescence microscopy (Zhang et al., 2011). We observed a statistically 
significant two-fold increase in the amount of Y1 RNA associating with S phase nuclei 
compared to non-S phase nuclei (Fig. S3B). Flow cytometry profiles indicated that 
non-S phase nuclei consist >95% of G1 phase and <5% of G2 phase (not shown).  
Taken together, we conclude that significantly more Y RNA molecules associate with 
S phase nuclei than with G1 phase nuclei. 
 
Y RNAs associate with early-replicating euchromatin in G1 phase 
Y RNAs associate with unreplicated chromatin at the G1 to S phase transition (Zhang 
et al., 2011). We therefore investigated whether Y RNAs associate with particular 
DNA replication timing domains in G1 phase nuclei in vitro (Fig. 4). 
To label replication timing domains, we pulse-labelled replicating DNA in 
asynchronously proliferating HeLa cells for 5 mins with 5-ethynyl-2-deoxuridine (EdU) 
in vivo and chased the cells without EdU for 11 hours into the subsequent G1 phase. 
We isolated the nuclei and incubated them in the cell-free system with fluorescent 
Alexa-488-labelled Y RNAs. S phase nuclei present in this reaction were identified by 
incorporation of digoxigenin-dUTP in vitro, and subsequently excluded from the 
analysis. Based on the patterns of replication foci pre-labelled in the previous S phase 
in vivo (Berezney et al., 2000), we were able to class replication timing domains in 
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these G1 phase nuclei as early-, mid- or late-replicating. We then visualised and 
quantified the overlap between sites of associated Y RNAs and pre-labelled 
replication timing domains (Fig. 4). 
Y1 and Y5 RNAs associated predominantly with early-replicating domains, and to a 
lesser extent, if at all, with mid- and late-replicating domains in G1 phase nuclei (Fig. 
4A). We quantified the extent of co-localisation between sites of associated Y RNAs 
and the pre-labelled replication timing domains as Pearson Correlation Coefficients 
(Fig. 4B). Coefficients of 0.0 to ±0.19 are taken as no correlation, ±0.2 to ±0.29 as 
weak, ±0.3 to ±0.39 as moderate, ±0.4 to ±0.69 as strong, ±0.7 to ±0.99 as very 
strong and ±1 a perfect positive or negative correlation, respectively. Y1 and Y5 
RNAs showed a strong positive correlation with early-replicating domains in G1 phase 
nuclei, but no or weak positive correlation with mid-replicating domains, and no or 
weak negative correlation with late-replicating domains (Fig. 4B). 
We conclude that Y RNAs associate preferentially with early-replicating chromosome 
domains in G1 phase, whilst they are not enriched at mid- and late-replication timing 
domains. Next, we investigated the dynamic association of Y RNAs with chromatin 
during S phase. 
 
Y RNAs re-associate with replicated chromatin before the end of S phase 
S phase is characterised by an elevated association of Y RNAs with chromatin (see 
Figs 2, 3, S2 and S3), yet chromatin-associated Y RNAs were seen excluded from 
sites of active DNA replication in vitro (Zhang et al., 2011). We therefore investigated 
if Y RNAs are able to re-associate with replicated chromatin during later stages of S 
phase (Fig. 5). First, we pulse-labelled active sites of ongoing DNA replication in 
asynchronously proliferating HeLa cells with EdU, and chased the cells without EdU 
for 0, 2.5 and 5 hours in vivo. Nuclei were then isolated and incubated in vitro for a 
second pulse-label with digoxigenin-dUTP in the presence of fluorescent Alexa-488-
labelled Y RNAs. Only S phase nuclei showing both replication labels were included 
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in the analysis. The zero time chase provides the positive control for a co-localisation 
of DNA replication foci active in vivo and after isolation in vitro. Longer chase times 
selectively mark already replicated chromatin domains with EdU in comparison to the 
active replication sites marked with digoxigenin-dUTP. We then investigated whether 
Y RNAs are present at sites of active DNA replication and associate with regions that 
were recently replicated during the same S phase. 
At the zero hour control chase (Fig. 5A, left), intranuclear sites of DNA replication in 
vivo (blue) and in vitro (red) overlap and show a magenta colour in the merged 
images. Associated Y1 and Y5 RNA are excluded from these DNA replication sites 
and show a green pattern (Fig. 5A). After 2.5 hours chase (Fig. 5A, middle), sites of 
DNA replication in vivo and in vitro have diverged and display separate foci of already 
replicated and actively replicating DNA, respectively. Y RNAs were found associated 
mostly with non-replicating sites (green), but some overlap with replicated sites 
became also apparent (cyan). After 5 hours chase (Fig. 5A, right), the DNA replication 
sites labelled in vivo and in vitro have completely diverged, revealing blue and red 
foci, respectively. Y RNAs appeared mostly on non-replicating chromatin (green) but 
were also found at already replicated sites labelled in vivo (cyan), in particular in 
those nuclei that were in early S phase during the first pulse. Taken together, these 
observations suggest that Y RNAs are able to associate with replicated chromatin in 
these nuclei. 
To substantiate these observations, we quantitated the overlap between these sites 
by determining the pairwise Pearson correlation coefficients of the three labels (Fig. 
5B). Sites of replicated chromatin in vivo and in vitro were very strongly positively 
correlated at the zero hour chase and declined to moderate and eventually very low 
or no correlation with increasing chase time (Fig. 5B, left panels). Importantly, no 
correlation was detected between associated Y1 or Y5 RNAs with sites of ongoing 
DNA replication (Fig. 5B, middle panels and 0h chase, right panels), consistent with 
earlier observations (Zhang et al., 2011). Strikingly, sites of associated Y1 RNA 
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correlated moderately and strongly with sites of replicated chromatin at 2.5 and 5h 
chase time, respectively (Fig. 5B, top right panel). The correlation of sites of Y5 RNA 
association with replicated chromatin increased only slightly but discernibly during this 
time (Fig. 5B, bottom right panel). 
We conclude that Y RNAs re-associate with replicated chromatin during S phase 
within a few hours after it has been replicated, and Y1 RNA re-associates more 
efficiently with these replicated domains than Y5 RNA. 
 
Chromatin association dynamics of Y RNAs are concordant with ORC 
Y RNAs interact biochemically with DNA replication initiation proteins, including the 
origin recognition complex ORC and the pre-RC proteins CDT1 and CDC6, and they 
co-localise with these proteins and MCM2-7 on unreplicated chromatin at the G1 to S 
phase transition (Collart et al., 2011; Zhang et al., 2011). We therefore investigated 
whether the dynamic association of Y RNAs with chromatin during S phase is 
mirrored by the association dynamics of ORC, the pre-RC, or other replication fork-
associated proteins. We used the same pulse labelling approach as in Fig. 5, but 
detected sites of candidate proteins by indirect immunofluorescence microscopy (Figs 
6 and S4A). 
Sites of chromatin-associated ORC (subunits ORC2 and ORC3) did not correlate with 
sites of ongoing DNA replication (Figs 6A, B and S4A). Like Y RNAs, ORC re-
associated with replicated chromatin domains a few hours after their replication 
during the same S phase (Figs 6A, B and S4A). The pre-RC proteins Cdc6 and Cdt1 
also did not localise to sites of ongoing DNA replication, but then did not re-associate 
effectively with replicated chromatin (Fig. 6C, D). The pre-RC and replicative DNA 
helicase subunit MCM3 correlated moderately with active replication foci but not 
anymore with replicated chromatin domains (Fig. 6E), consistent with its role as a 
licensing factor. Finally, sites of the replication fork protein PCNA correlated very 
strongly with active DNA replication foci and the correlation decreased to moderately 
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low levels with replicated domains (Fig. 6F). 
In conclusion, the chromatin association dynamics of the non-coding Y RNAs are 
concordant with those of ORC, but not with pre-RC, or replication-fork associated 
proteins. 
 
Y1 RNA co-localises with chromatin-associated ORC during the cell cycle 
In the final experiments, we investigated the co-localisation of replication proteins with 
Y1 and Y5 RNAs in isolated cell nuclei throughout the cell cycle.  
We observed a strong positive correlation of the chromatin association sites of 
ORC2/3 with Y1 RNA at all points of the cell cycle, but not with Y5 RNA (Figs 7A, B; 
S4B). This corroborates a functional interaction between Y1 RNA and ORC, 
suggested by previous biochemical interaction and chromatin binding studies (Collart 
et al., 2011; Zhang et al., 2011). In contrast, sites of Cdc6 protein did not correlate 
with Y1 or Y5 RNAs at any stage of the cell cycle (Fig. 7C). Similarly, sites of Cdt1 
protein did not correlate with Y1 RNA, but generally showed a weak positive 
correlation with Y5 RNA (Fig. 7D). The sites of MCM3 protein correlated moderately 
positively with Y1 RNA in non-S and early S phase nuclei but not any more in mid and 
late S phase (Fig. 7E), when MCM proteins become displaced locally from replicated 
chromatin under these conditions (Krude et al., 1996). We observed no correlation of 
MCM3 protein sites with Y5 RNA during the entire cell cycle. 
Furthermore, sites of the replication fork protein PCNA and of the heterochromatin 
protein HP1α did not correlate with Y1 or Y5 RNAs at any time of the cell cycle (Fig. 
7F, G), demonstrating that Y RNAs do not associate preferentially with replication 
forks or heterochromatin domains at any time. 
Interestingly, the association of Y RNAs with nucleoli differed between the two Y 
RNAs (Fig. 7H). Sites of Y1 RNA appeared to be excluded from sites of nucleolin 
protein (Fig. S4C) and these sites showed no, or very weak negative correlation 
throughout the cell cycle (Fig. 7H). In contrast, sites of Y5 RNA overlapped visually 
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with nucleolin in non-S and early S phase (Fig. S4C), and these sites correlated 
positively and strongly at these stages (Fig. 7H). This positive correlation decreased 
at the time when these nucleolar sites replicated in mid S phase (Fig. S4C), and 
eventually reached no correlation in late S phase (Fig. 7H). 
In conclusion, Y1 RNA shows highly concordant chromatin association dynamics with 
ORC throughout the cell cycle. Y5 RNA associates preferentially with sites of 
unreplicated nucleoli, suggesting that these two Y RNAs may be involved in different 
nuclear processes. 
 
 
Discussion 
In this paper, we provide a quantitative analysis of Y RNA levels in a panel of human 
cells and of their intracellular partition into soluble and chromatin-associated cellular 
fractions. We have used two independent approaches: (i) quantitative RT-PCR and 
(ii) chromatin-association of fluorescently labelled Y RNAs in a physiological cell-free 
system. We found that overall Y RNA levels are comparable between proliferating 
cancer and non-cancer cells, but decrease substantially in quiescent cells. Compared 
to G1 phase, two- to four-fold increased amounts of Y RNAs associate with 
euchromatin during S phase, both with unreplicated chromatin in early S and again 
with replicated chromatin in late S. The chromatin association dynamics of Y1 RNA 
mirrors those of the origin recognition complex ORC. 
 
Y RNA abundance 
Since their discovery in the early 1980s (Hendrick et al., 1981; Lerner et al., 1981), Y 
RNAs have been described as relatively abundant small RNAs. Here, we have used 
cell fractionation and quantitative RT-PCR to determine the absolute numbers of Y 
RNA molecules in a panel of human cells. We found that overall Y RNA amounts 
varied non-systematically between human cell lines with an overall number of about 
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1.3 million Y RNA molecules per cell, ranging between 0.3 and 2.5 million for different 
cell lines. Compared to other species, this number is in range with ~1 million Y RNA 
molecules per Xenopus laevis egg and exceeds the ~0.1 million per zebrafish egg 
(Collart et al., 2011). These numbers remain constant per embryo after fertilisation 
until the mid-blastula transition (MBT), so that the actual number per cell decreases 
during these early embryonic cycles. After MBT, when Y RNA become essential for 
DNA replication, cell proliferation and embryo viability (Collart et al., 2011), the 
amounts of Y RNAs per embryo increase by induction of zygotic transcription of the Y 
RNA genes to compensate for the increasing number of cells per embryo (Collart et 
al., 2011). Any quantitative differences between these three different datasets will be 
influenced by differences between species and by different protocols of RNA 
extraction and RT-PCR quantification. The relatively high expression levels of Y RNA 
in vertebrate cells suggest that they may exert their physiological function in a 
structural or stoichiometric manner, or that they are present in excess of their 
physiological requirements. 
 
Y RNA expression and cancer 
An earlier investigation of relative Y RNA abundance in human cancer tissues by 
quantitative RT-PCR established that Y RNAs were more abundant in human solid 
tumours than in corresponding normal tissues (Christov et al., 2008). Our data 
reported here offer a physiological explanation for this observation. We found that 
overall expression levels of Y RNA do not differ significantly between different 
proliferating cell lines of cancer and non-cancer origin. In contrast, Y RNA levels are 
significantly reduced in quiescent cells, and their expression is induced when 
quiescent cells enter the proliferative cell cycle. Therefore, elevated Y RNA levels in 
solid tumour samples can best be explained by the higher proportions of proliferating 
cells in tumours than in corresponding normal tissues. As consequence, we propose 
that elevated Y RNA levels should not necessarily be regarded as a cancer marker, 
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but as a potential cell proliferation marker. 
 
Chromatin association of Y RNAs  
Early determinations of intracellular localisation and partitioning of Y RNAs between 
cytoplasm and nucleus have been discordant (reviewed by (Hall et al., 2013; 
Kowalski and Krude, 2015; Pruijn et al., 1997)). Northern blotting after enucleation 
and cell fractionation indicated that Y RNAs were predominantly, if not exclusively, 
cytoplasmic in Xenopus laevis oocytes and cultured mammalian cells (Gendron et al., 
2001; O'Brien et al., 1993; Peek et al., 1993; Simons et al., 1994). However, in situ 
hybridisation and electron microscopy in cultured human cells showed discrete sites 
of Y RNAs in the nucleus and the cytoplasm (Farris et al., 1997; Matera et al., 1995). 
Physiological binding studies then demonstrated that Y RNAs associate efficiently 
with chromatin in vitro (Zhang et al., 2011). A conclusion from these studies is that Y 
RNA expression levels and their intracellular partition are found to vary depending on 
the methodologies used for their detection, and on the physiological state of the cells 
investigated (Kowalski and Krude, 2015). 
In this paper we provide the first comprehensive quantitative analysis of intracellular 
human Y RNAs during the cell cycle. We obtained mutually consistent results by cell 
fractionation and quantitative RT-PCR, and by association assays using fluorescently 
labelled Y RNAs. About 10% of total Y RNA was associated with chromatin in 
asynchronously proliferating cells, requiring an extraction with 0.5M salt to isolate 
them from the nuclear structure. In synchronised cells, the amount of chromatin-
associated Y RNA is two to four-fold higher in S phase compared to G1 phase or 
mitosis. We were not able, however, to investigate homogenous G2 phase cells as 
preparations were always contaminated with significant amounts of late S phase 
cells, due to the very short relative duration of G2 phase in the cells investigated. We 
would therefore propose that the preferential association of Y RNAs with S phase 
chromatin might suggest a functional involvement with replicating chromatin, 
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consistent with the established essential role of Y RNAs for the initiation step of DNA 
replication (Christov et al., 2006; Christov et al., 2008; Collart et al., 2011; Gardiner et 
al., 2009; Kowalski and Krude, 2015; Krude et al., 2009; Wang et al., 2014). 
In human cells, about 30,000 replication origins become activated during S phase 
(Berezney et al., 2000; Huberman and Riggs, 1968), out of a pool of many more 
potential origins (Fragkos et al., 2015). We determined here that in synchronised 
human (HeLa) cells, about one million Y RNA molecules are associated with 
chromatin throughout S phase. Therefore, an order-of-magnitude excess of Y RNA 
molecules would be associated with chromatin per activated replication origin at any 
stage of S phase. 
Our fluorescence-based Y RNA binding studies showed a preferential association of 
Y RNAs with early-replicating euchromatin and not with late-replicating 
heterochromatin marked by HP1α protein in vitro. We also observed a positive 
overlap correlation with sites of associated ORC, supporting a reported biochemical 
interaction between ORC and Y RNAs (Zhang et al., 2011; Collart et al., 2011). It is 
currently unknown if Y RNAs associate with early-firing replication origins in the 
human genome directly, or if they associate more dispersedly across early-replicating 
chromosome domains. A recent genome-wide mapping of ~25,000 replication origins 
activated in a Y RNA-dependent manner in vitro located these origins predominantly 
in early-replicating chromosome domains (Langley et al., 2016). Therefore, sites of Y 
RNA association, and sites where their function is executed, appear to converge on 
early-replicating euchromatin. Systematic mutagenesis indicated that a specific 
association of Y1 RNA with open chromatin involves the loop domain (Zhang et al., 
2011). Future technology development would be therefore required to enable 
genome-wide mapping of the sites of chromatin-associated Y RNA at higher 
resolution. 
All four Y RNAs are functionally redundant with each other as essential DNA 
replication initiation factors (Christov et al., 2006; Christov et al., 2008; Collart et al., 
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2011; Gardiner et al., 2009; Kowalski and Krude, 2015; Krude et al., 2009; Wang et 
al., 2014), and they associate with open chromatin in vitro (Zhang et al., 2011). Using 
competitive in vitro binding assays, human Y1, Y3 and Y4 RNA were shown to co-
localise on open chromatin with each other after binding to chromatin. Y5 RNA also 
co-localised with Y1 RNA, but also showed association with additional sites 
overlapping nucleoli. Therefore, we investigated here Y1 RNA (representing the 
collective behaviour of Y1, Y3 and Y4 RNAs) and Y5 RNAs separately here. In 
addition to an association with euchromatic sites, Y5 RNA also co-localised with 
nucleolin on nucleolar chromatin domains in G1 and S phase until the time of their 
replication in mid/late S phase, when Y5 RNA was displaced from these sites locally. 
Nucleolin is a multifunctional protein with roles in rRNA processing, ribosome 
biogenesis and nucleo-cytoplasmic transport (Ginisty et al., 1999). It binds to the loop 
domain of Y RNAs and can form cytosolic RNPs with all four Y RNAs in human cells 
(Fabini et al., 2001; Langley et al., 2010). However, the interaction between Y RNAs 
and soluble nucleolin is not required for Y RNA function in DNA replication, as Y 
RNA/nucleolin RNPs can be immunodepleted from human cell extracts without 
compromising the ability to initiate DNA replication in vitro (Langley et al., 2010). 
Human Y5 RNA interacts with the ribosomal protein L5 (Hogg and Collins, 2007), 
which also associates with 5S rRNA (Steitz et al., 1988). Therefore, in addition to its 
conserved function in DNA replication, Y5 RNA may also have a second role in 
nucleolar function, possibly in rRNAs biogenesis. Such a diversification of function 
would further support the modular nature of Y RNAs (Kowalski and Krude, 2015). 
 
Are Y RNAs licensing factors? 
In nuclei of cells synchronised at the G1 to S phase transition, Y RNAs were seen 
bound to chromatin prior to initiation of DNA replication, but became absent from 
active replication foci after replication was initiated in vitro (Zhang et al., 2011). 
Because Y RNAs are functionally essential for the initiation step (Christov et al., 2006; 
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Krude et al., 2009), it was proposed that they may act in a manner consistent with the 
‘activator’ function of the original ‘licensing factor’ model of once-per cell cycle control 
of origin firing (Zhang et al., 2011). In this model (Blow et al., 1987; Laskey et al., 
1981), the ‘activator’ or ‘licensing factor’ binds to and marks unreplicated chromatin in 
G1 phase, and it is required for initiation of DNA replication. Following origin 
activation, it is then displaced from the origin site after initiation and prevented from 
rebinding to replicated DNA until the subsequent G1 phase, thus limiting initiation to 
once per cell cycle. Our data reported here clearly dismiss the hypothesis that Y 
RNAs are licensing factors A substantial fraction of Y RNAs re-associates with 
replicated chromatin during later stages of S phase, which is inconsistent with the 
established activity of a licensing factor. 
 
Concordant dynamics of Y RNAs and ORC 
The hetero-hexameric origin recognition complex ORC is conserved in eukaryotes 
and directs the assembly of the pre-replication complex at replication origins by a 
stepwise assembly with Cdc6, and MCM2-7/Cdt1 on chromosomal DNA (Costa et al., 
2013; Fragkos et al., 2015; Siddiqui et al., 2013). The crystal structure of Drosophila 
ORC showed that five subunits ORC1-5 form a stable ring-shaped structure that can 
encircle DNA, whilst the ORC6 subunit is more loosely associated (Bleichert et al., 
2015). Following pre-RC assembly in G1 phase, ORC disassembles partially as 
ORC1 is degraded while ORC2-6 remain stable and keep an association with 
chromatin (Mendez et al., 2002; Tatsumi et al., 2003). The association of human ORC 
with chromatin and replication origins is regulated during the cell cycle, showing 
increased association in G1/S compared to G2/M phases (Gerhardt et al., 2006; 
Prasanth et al., 2004; Siddiqui and Stillman, 2007). ORC3 shows no obvious co-
localisation with replication foci suggesting a displacement from replicating chromatin, 
however, in late S phase cells a weak and apparently euchromatic population of 
ORC3 remains detectable (Fig. 6 of (Siddiqui and Stillman, 2007). Here, we 
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compared the chromatin association dynamics of human Y RNAs with ORC2 and 
ORC3 subunits during cell cycle progression and found that Y1 RNA and ORC2/3 are 
highly and significantly correlated. Furthermore, Y RNAs do not co-localise with 
replication foci, as seen independently before (Zhang et al., 2011), suggesting a 
temporal and local displacement during replication.  
ORC interacts biochemically with immobilised Y RNAs in human nuclear extracts 
(Collart et al., 2011; Zhang et al., 2011), demonstrating stable direct or indirect 
physical interactions. Importantly, antisense morpholino oligonucleotides against Y 
RNAs inhibited Y RNA-dependent initiation of DNA replication and the biochemical 
interaction between Y RNAs and ORC (Collart et al., 2011). Therefore, ORC and Y 
RNAs are likely to interact in a common functional pathway, leading to the initiation of 
DNA replication. Several non-coding RNAs have been shown to facilitate recruitment 
of ORC to specific replication origin sites on chromosomal DNA in Tetrahymena and 
Epstein Barr virus (Mohammad et al., 2007; Norseen et al., 2008). In contrast, Y 
RNAs are actually recruited to chromatin themselves in an ORC-dependent manner in 
developing Xenopus embryos after the MBT (Collart et al., 2011). These observations 
suggest an ORC-dependent function for Y RNAs that is not related to the recruitment 
of ORC to replication origins. It is also unlikely that Y RNAs are required for the 
recruitment of the replicative helicase MCM2-7 as part of the licensing reaction 
because this can be achieved with purified proteins in the absence of Y RNAs, at 
least in budding yeast (Yeeles et al., 2015). It is thus conceivable that Y RNAs are 
involved in another ORC-dependent aspect of chromatin dynamics during the 
initiation of DNA replication, and future work is therefore required to elucidate the 
molecular mechanisms of this pathway. 
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Materials and Methods 
 
Cell culture and synchronisation 
All human cell lines were grown as monolayers in Gibco DMEM (Invitrogen), 
supplemented with 10% FBS (Invitrogen) and 1% penicillin/streptomycin (PAA) at 
37°C and 10% CO2 as detailed (Krude et al., 1997). Cells were free of microbial 
contamination. Detailed specifications are shown in supplementary table S1. 
HeLa cells were chemically synchronised at different points of the mitotic cell cycle by 
releasing from a double thymidine block (two times 24 hours at 2.5mM thymidine, 
separated by 12 hours without thymidine) as detailed (Krude et al., 1997). G1 phase 
cells were acquired by releasing from double thymidine block for 12, 15 and 18 hours 
to give early, mid and late G1 cells, respectively. S and G2 phase cells were obtained 
by releasing them from a double thymidine block for 0.5, 2.5, 5.5 and 7 hours to give 
early S, early/mid S, mid S and late S/G2 cells, respectively. Mitotic cells were 
obtained by an 11 hour release from a double thymidine block into media containing 
40ng/ml nocodazole (Calbiochem). 
EJ30 and HCA-7 cells were made quiescent through serum starvation in DMEM 
containing 0.5% FBS for 15 days (Krude, 1999), while quiescence was achieved in 
RPE-1 cells by contact inhibition through cultivating confluent cells in DMEM 
containing 10% FCS for 7 days. Quiescent cells were released into the proliferative 
cell cycle by sub-cultivation at five times lower cell densities in fresh DME containing 
10% FBS.  
Synchronisation was confirmed by flow cytometry of isolated nuclei stained with 
propidium iodide, and S phase indices were determined by run-on replication of 
isolated nuclei incubated in a cytosolic extract from proliferating HeLa cells for 5 mins 
in the presence of digoxigenin-dUTP (Christov et al., 2006). 
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Cell fractionation and Y RNA quantification  
Cells were fractionated into nuclei and cytosol by hypotonic treatment, dounce 
homogenisation and centrifugation at 3,000 g as described (Zhang et al., 2011). To 
allow quantification of associated RNAs on a per-cell basis, the total volumes of cell 
lysates were recorded and the concentrations of nuclei were determined on a 
haemocytometer after dounce homogenisation. Cell cycle positions were determined 
by flow cytometry of isolated nuclei. To prepare nuclear extracts, pelleted nuclei were 
resuspended in 5 times their volume of hypotonic buffer containing 0.5M NaCl and 
incubated under continuous agitation for 30 minutes at 4 °C. Nuclei were pelleted 
again at 13,000 rpm for 30 minutes and removed.  
Total RNA was isolated from the cytosolic and the nuclear extracts by phenol 
extraction and ethanol precipitation, and their concentrations were measured by 
nanodrop spectrophotometry as detailed (Zhang et al., 2011). Y RNAs in these 
extracts were quantified by RT-PCR using human Y RNA specific primer pairs 
(Christov et al., 2006). Serial dilutions of known quantities of human Y RNA-encoding 
plasmid DNA molecules were used as specific calibrators for each Y RNA-specific 
RT-PCR. Absolute numbers of Y RNA molecules present per cell in the soluble 
cytosolic and nuclear extracts were calculated using the information on total yield 
volumes of lysates and fractionated extracts, and of nuclear concentrations in the 
lysates. For the calculations we assumed 100% efficiency of cDNA synthesis. 
Proportions of chromatin-associated Y RNAs were determined as the ratio of 
chromatin-associated over the sum of soluble and chromatin-associated amounts. 
 
Synthesis of Y RNAs 
 Synthesis, purification and coupling of human Y1 and Y5 RNAs to Alexa-Flour-488 
(Invitrogen) was performed exactly as described (Zhang et al., 2011).  
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Association of fluorescent Y RNAs with chromatin in vitro and co-localisation 
analyses 
For pre-labelling of DNA replication sites in vivo, asynchronously proliferating HeLa 
cells were pulse-labelled with 10µM 5-ethynyl-2-deoxuridine (EdU, Invitrogen) for 5 
minutes in vivo, with or without further chase in the absence of EdU before the 
isolation of cell nuclei.  
The chromatin association of fluorescent Y RNAs in vitro was quantified as described 
(Zhang et al., 2011), Briefly, isolated cell nuclei (0.6-1x106 nuclei per reaction) were 
incubated for 1 minute at 37°C with 300 ng of Alexa-fluor-488-conjugated Y1 or 5 
RNA in physiological buffer with cytosolic extract of asynchronously proliferating HeLa 
cells (150μg protein per reaction) and 150pmol digoxigenin-dUTP (Roche). Nuclei 
were fixed by 4% para-formaldehyde and spun onto polylysine-coated glass 
coverslips. EdU was detected using the Click-it imaging kit (Invitrogen) and dig-dUTP 
was detected using rhodamine-conjugated anti-digoxigenin antibodies (Boehringer 
Mannheim), as described (Zhang et al., 2011). Nuclear proteins were detected by 
indirect immunofluorescence microscopy in the presence of RNAse inhibitor (Zhang 
et al., 2011). Primary antibodies against the following proteins were used: ORC2, 
ORC3, MCM3 (all from Aloys Schepers, Helmholtz Centre Munich, Germany); 
nucleolin (from Hans Stahl, University of Homburg, Germany); Cdt1 (H-300, sc28262, 
Santa Cruz Biotechnology); Cdc6 (H-304, sc8341, Santa Cruz Biotechnology); PCNA 
(PC10, sc-56, Santa Cruz Biotechnology); HP1α (clone 15.19s2, 05-689, EMD 
Millipore). Chromosomal DNA was counterstained with propidium iodide or DAPI. 
Confocal fluorescence microscopy was performed on a Leica SP1 microscope using 
63 x lens magnification with a pinhole setting of 90μm. Co-localisation was quantified 
by determining thresholded Pearson Correlation Coefficients using Volocity 6.3 
software from Perkin Elmer.  
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Legends to the Figures 
 
Figure 1. Quantification of Y RNA levels in asynchronously proliferating human 
cell lines. The indicated cell lines were grown as asynchronously proliferating 
cultures. Total RNA was isolated from the (A) cytosolic and the (B) chromatin-
associated fractions of these cell cultures. The absolute numbers of the indicated Y 
RNA molecules present in these intracellular fractions were determined by 
quantitative RT-PCR. Average values are shown for both cancer and non-cancer 
derived cell lines. Mean values of 3 independent experiments (n=3) are shown. 
Brackets indicate data grouped for statistical tests (i.e. cancer vs non-cancer), ns 
indicates no significance (t-tests, two-tailed, p > 0.3). (C) Proportions of chromatin-
associated Y RNAs. Individual Y RNAs are colour-coded as indicated. 
 
Figure 2. Quantification of Y RNA levels during the cell cycle. HeLa cells were 
synchronised in the indicated phases of the cell cycle (see Materials and Methods). 
(A) Confirmation of cell synchrony by flow cytometry. A colour-coded overlay of 
individual flow cytometry profiles is shown, positions of unreplicated (2n) and fully 
replicated (4n) DNA content are indicated. (B) S phase indexes. Percentages of S 
phase nuclei were determined for each synchronised cell population by nuclear run-
on replication in vitro. (C and D) Quantification of intracellular Y RNA levels. Total 
RNA was isolated from the (C) cytosolic and the (D) chromatin-associated fractions of 
the synchronised cells. Absolute numbers of the indicated Y RNA molecules were 
determined by quantitative RT-PCR. Brackets indicate data grouped for statistical 
tests (i.e. mitosis vs G1, G1 vs S), *** and ns represent p values of ≤ 0.001 and > 
0.05 respectively, as determined by t-tests (two-tailed). (D) Proportions of chromatin-
associated Y RNAs. Mean values and standard deviations of three independent 
experiments (n=3) are shown. 
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Figure 3. Y1 RNA preferentially associates with S phase nuclei in vitro.  Nuclei 
were prepared from synchronised HeLa cells and incubated in vitro with fluorescent 
Alexa-488-labelled Y1 RNA, U2 RNA or 5S RNA and HeLa cytosolic extract for 1 
minute. Nuclei were fixed and the fluorescent Y RNAs associated with the nuclear 
structure were visualised by confocal fluorescence microscopy. (A) Representative 
micrographs showing association of U2, 5S and Y1 RNAs with G1 and S phase 
nuclei. Fluorescent Alexa-488-labelled RNAs are shown in green and nuclear DNA is 
counterstained with propidium iodide (red). Scale bar, 10µm. (B) Quantification of 
RNA binding to isolated cell nuclei. Alexa-488-RNA fluorescence of the indicated 
RNAs was recorded by confocal microscopy, and integrated pixel density analysis 
was performed by ImageJ. Results of a representative binding experiment are shown 
as box and whisker plots. The 5th to 95th percentiles are displayed, red asterisks 
indicate mean values; n≥329 nuclei for each sample. (C) Quantification of Y1 RNA 
binding to nuclei of synchronised cells. Y1 RNA association with the indicated nuclei 
was analysed as in panel B, n≥457 nuclei for each sample. Analysis of variance (one-
way ANOVA) was used to determine significance of variance between groups. 
Brackets indicate individual and grouped data sets used for ANOVA; ns, ** and *** 
represent p values of > 0.05, ≤ 0.01 and ≤ 0.001 respectively. 
 
Figure 4. Y RNAs associate with early-replicating euchromatin during G1 phase. 
(A) Chromatin association of Y RNAs with discrete DNA replication timing domains. 
To label replication timing domains, asynchronously proliferating HeLa cells were 
pulse labelled in vivo with EdU for 5 minutes and chased into the subsequent G1 
phase by adding EdU-free media for 11 hours. Nuclei were isolated and incubated 
with fluorescent Alexa-488-labelled Y RNAs (green) and digoxigenin-dUTP in a cell 
free DNA replication system for 5 minutes in vitro. EdU was detected using click-it 
chemistry (blue) and digoxigenin-dUTP was detected using rhodamine-conjugated 
anti-digoxigenin antibodies (red). G1 nuclei were identified by their absence of 
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digoxigenin incorporation. Early-, mid- and late-replicating chromatin domains were 
identified by patterns of EdU pulse-labelled DNA replication foci (Berezney et al., 
2000). Sites of chromatin-associated Y1 RNA (top panel) and Y5 RNA (bottom panel) 
were detected by confocal fluorescence microscopy in G1 phase nuclei in comparison 
to replicating chromatin domains in these G1 phase nuclei (merge). Scale bar, 10µm. 
(B) Quantitative co-localisation analysis. Pearson’s correlation coefficients were 
determined for the pixel-by-pixel overlap between sites of chromatin-associated Y1 
(top panel) or Y5 RNA (bottom panel) and early-, mid- and late-replicating chromatin 
domains in G1 phase nuclei. Box and whisker plots of the Pearson’s correlation 
coefficients are shown, red asterisks specify mean values. Numbers of independent 
nuclei analysed for each dataset are indicated (n). 
 
Figure 5. Chromatin binding dynamics of Y1 and Y5 RNA during S phase. To 
differentially label unreplicated, replicating, and replicated chromatin domains, 
asynchronously proliferating HeLa cells were first pulse-labelled with EdU for 5 
minutes in vivo and then chased by adding EdU-free media for 0, 2.5 and 5 hours. 
Nuclei were isolated and incubated in a cytosolic extract from proliferating HeLa cells 
supplemented with fluorescent Alexa-488-labelled Y RNAs and digoxigenin-dUTP for 
5 mins in vitro. (A) Confocal microscopy. Intranuclear sites of EdU (blue) and 
digoxigenin-dUTP incorporation (red) and associated Y1 and Y5 RNA (green; top and 
bottom row, respectively) are shown for 0h (left), 2.5h (middle) and 5h chase time 
(right). Scale bar, 10µm. (B) Quantitative co-localisation analysis. Pearson’s 
correlation coefficients were determined pairwise for the pixel-by-pixel overlap 
between sites of EdU and digoxigenin pulses (left column), and between chromatin-
associated Alexa-488-labelled Y1 (top row) or Y5 RNA (bottom row) and sites of 
digoxigenin-dUTP (middle column) and EdU pulses (right column). Box and whisker 
plots of the Pearson’s correlation coefficients are shown; 100 nuclei were analysed 
for each time point. 
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Figure 6. Chromatin binding dynamics of replication proteins during S phase. 
The intranuclear sites of chromatin-associated replication proteins were determined 
by indirect immunofluorescent microscopy in relation to sites of replicated (EdU) and 
replicating chromatin (digoxigenin-dUTP), as detailed for Y RNAs in Fig. 5. 
Quantitative co-localisation analysis of Pearson’s correlation coefficients was 
performed pairwise for the pixel-by-pixel overlap between sites of (A) ORC2, (B) 
ORC3, (C) Cdc6, (D) Cdt1, (E) MCM3 and (F) PCNA with sites of digoxigenin-dUTP 
(left columns) and EdU pulses (right columns). Box and whisker plots of the Pearson’s 
correlation coefficients are shown; 100 nuclei were analysed for each time point. 
Representative confocal immunofluorescence micrographs of the association analysis 
of ORC2 and ORC3 are shown in supplementary Fig. S4A. 
 
Figure 7. Co-localisation of replication and chromatin marker proteins with Y1 
and Y5 RNAs during the cell cycle.  Asynchronously proliferating HeLa cells were 
pulse labelled with EdU for 5 minutes before isolating their nuclei. Nuclei were 
incubated in cytosolic extract from proliferating HeLa cells supplemented with 
fluorescent Alexa-488-labelled Y1 or Y5 RNA for 1 minute. EdU was detected using 
click-it chemistry and nuclei were sorted by their replication patterns into early-, mid- 
and late S phase; a lack of EdU incorporation was taken as non-S phase. 
Quantitative co-localisation analysis of Pearson’s correlation coefficients was 
performed pairwise for the pixel-by-pixel overlap between sites of (A) ORC2, (B) 
ORC3, (C) Cdc6, (D) Cdt1, (E) MCM3, (F) PCNA, (G) heterochromatin protein HP1α 
and (H) nucleolin with sites of Y1 RNA (left columns) and Y5 RNA (right columns). 
Box and whisker plots of the Pearson’s correlation coefficients are shown; the 
numbers of nuclei analysed for each time point are indicated (n). Representative 
confocal immunofluorescence micrographs of the co-localisation analysis of Y RNAs 
with ORC3 and nucleolin are shown in supplementary Figs S4B and S4C. 
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